Yes finally the words "met primary and secondary endpoints". I am surprised and happy that the results came within this quarter, and were so definitive. What would you like to see as an amendment to the PDD results that we have seen so far. Do you think positive actigraphy readouts would provide clarity. I have been very disappointed until now with the information provided by Anavex, but hopefully with this, there is a much clearer path to approval.